FOLD - Amicus Therapeutics Inc. (FOLD) CEO John Crowley on Q3 2020 Results - Earnings Call Transcript
Amicus Therapeutics, Inc. (FOLD) Q3 2020 Earnings Conference Call November 05, 2020, 08:30 AM ET Company Participants Andrew Faughnan - Director of IR John Crowley - Chairman & CEO Bradley Campbell - President & COO Mitch Goldman - SVP of Clinical Research Jeff Castelli - Chief Development Officer Daphne Quimi - CFO Hung Do - Chief Science Officer Conference Call Participants Anupam Rama - JPMorgan Ritu Baral - Cowen Joseph Schwartz - SVB Leerink Salveen Richter - Goldman Sachs Mike Ulz - Baird Evan Wang - Guggenheim Securities Presentation Operator Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Third Quarter 2020 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to
For further details see:
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q3 2020 Results - Earnings Call Transcript